Mental illness engineered in cloned monkeys

Hershikka Tourani

Chinese scientists have recently genetically edited monkey clones to “turn off” a sleep regulation gene, in order to better study sleep regulation disorders and mental illnesses in humans in the future. This controversial experiment highlights many ethical issues, including those surrounding animal rights, cloning and genetic engineering.

The experiment was conducted with CRISPR cas9, a pioneering genetic technology that acts as “molecular scissors”, essentially allowing scientists to select, cut, copy and paste genes with much more precision and ease than ever before. The researchers used this technology to “turn off” the BMAL1 gene in monkeys, a gene that plays a crucial part in circadian rhythm regulation.

“Disorder of circadian rhythm could lead to many human diseases, including sleep disorders, diabetic mellitus, cancer, and neurodegenerative diseases; our BMAL1 knockout monkeys, thus, could be used to study the disease pathogenesis as well as therapeutic treatments,” said Hung-Chun Chang, senior investigator at the Institute of Neuroscience. 

China is currently the only country to successfully clone primates, which are notoriously difficult to clone compared to other mammals. The cloning was said to be done in order to minimise the quantity of monkeys used, by limiting the genetic variation between monkeys and thus being able to isolate the effects of the “turned off” gene with a much smaller number of affected individuals.

The scientists considered this experiment to be a success as the genetically edited monkeys showed signs of “negative behaviour” such as depression, increased levels of anxiety, sleep disorders, and “schizophrenia like behaviours”. Newspapers in China claim that the clones would pave the way for more research into sleep disorders in humans. Unlike the controversial HIV editing experiment from last month which used human embryos, this experiment was fully legalised and approved by the Chinese government, but many bioethicists claim that it should not and would not be approved in countries with stricter ethical regulations.

Prominent American bioethicist Carolyn Neuhaus pointed out that the researchers had neither a scientific hypothesis nor a new treatment they were trying to prove or disprove, both critical elements to gaining access to work on primates. Rather, she claimed, the scientists were simply “turning off” a crucial gene to see what happened, likening it to deleting a “cryptically named file” off of a computer to see what would happen.

With the excitement surrounding the new genome editing technology CRISPR, it is imperative that both international legislative bodies and the public come to a consensus about where to draw the line with genetic engineering. If not, our decision to dither may come at the cost of further animal and human rights violations. 

Image: pixabay